Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response
Key Points
Key points are not available for this paper at this time.
Abstract
.
Like
Bookmark
Share
View Full Paper
Like
Bookmark
Share
View Full Paper
Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response | Synapse